FTHFX
Price
$46.16
Change
+$0.27 (+0.59%)
Updated
Jul 16 closing price
Net Assets
10.38B
SSMOX
Price
$10.99
Change
+$0.06 (+0.55%)
Updated
Jul 16 closing price
Net Assets
183.3M
Interact to see
Advertisement

FTHFX vs SSMOX

Header iconFTHFX vs SSMOX Comparison
Open Charts FTHFX vs SSMOXBanner chart's image
FullerThaler Behavioral Sm-Cp Eq R6
Price$46.16
Change+$0.27 (+0.59%)
VolumeN/A
Net Assets10.38B
Steward Values Enhanced SmMidCapR6
Price$10.99
Change+$0.06 (+0.55%)
VolumeN/A
Net Assets183.3M
FTHFX vs SSMOX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FTHFX vs. SSMOX commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTHFX is a Buy and SSMOX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FTHFX has more cash in the bank: 10.4B vs. SSMOX (183M). SSMOX pays higher dividends than FTHFX: SSMOX (1.20) vs FTHFX (0.76). FTHFX was incepted earlier than SSMOX: FTHFX (14 years) vs SSMOX (8 years). FTHFX (0.63) is less costly to investors than SSMOX (0.53). SSMOX has a lower initial minimum investment than FTHFX: SSMOX (0) vs FTHFX (1000000). FTHFX annual gain was more profitable for investors over the last year : -3.83 vs. SSMOX (-7.15). FTHFX return over 5 years is better than : 92.20 vs. SSMOX (3.53).
FTHFXSSMOXFTHFX / SSMOX
Total Expense Ratio0.630.53119%
Annual Report Gross Expense Ratio0.630.53119%
Fund Existence14 years8 years-
Gain YTD1.035-1.265-82%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets10.4B183M5,683%
Annual Yield % from dividends0.761.2064%
Returns for 1 year-3.83-7.1554%
Returns for 3 years44.47-7.98-558%
Returns for 5 years92.203.532,613%
Returns for 10 years140.44N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SCHLX39.36N/A
N/A
DWS Health and Wellness S
BEMIX10.29N/A
N/A
Brandes Emerging Markets Value I
DGIGX39.83N/A
N/A
BNY Mellon Appreciation I
GQLIX33.90N/A
N/A
GMO Quality I
MDOAX11.16N/A
N/A
Morgan Stanley Developing Opportunity A